Ads

 

Ads

 

Ads

 

World Top 100 Biotechnology Companies List by Market Cap as of August 2026

World Top 100 Biotechnology Companies List by Market Cap as of August 2026, World Biggest 100 Biotechnology Companies by Market Cap, World Largest 100 Biotechnology Companies in the World by market cap as of August 2026.

Metatag Title
World Top Biotechnology Companies in 2026
Metatag Abstract
World Largest Biotechnology Companies by Market Cap in 2026, World Top Biotechnology Companies by Market Cap in 2026.
  1. Revvity Inc.

    World Rank (Aug-2026)
    1,777
    Market Cap (Aug-2026)
    13.038 Billion USD
    World Rank (Jan-05-2024)
    1,306
    Market Cap (Jan-05-2024)
    13.293 Billion USD
    World Rank (Jul-30-2023)
    1,194
    Market Cap (Jul-30-2023)
    15.118 Billion USD
    World Rank (Dec-25-2022)
    941
    Market Cap (Dec-25-2022)
    17.764 Billion USD
    World Rank (Jan-07-2022)
    915
    Market Cap (Jan-07-2022)
    22.92 Billion USD
    Annual Revenue in USD
    2,856 Million USD
    Annual Operating Income in USD
    357 Million USD
    Annual Net Income in USD
    241 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    Stock Category
    Company Profile

    Revvity is a biotechnology company that enables scientists, researchers and clinicians to address their most critical challenges across science and healthcare. With a mission focused on innovating for a healthier world, they deliver unique solutions to serve the diagnostics, life sciences, food and applied markets. They had 12,500 employees worldwide. Headquarters is in Massachusetts, USA.

    As on 2022, PerkinElmer has 16,000 employees.

  2. Exelixis

    World Rank (Aug-2026)
    1,826
    Market Cap (Aug-2026)
    12.696 Billion USD
    World Rank (Jan-05-2024)
    2,140
    Market Cap (Jan-05-2024)
    7.383 Billion USD
    World Rank (Jul-30-2023)
    2,387
    Market Cap (Jul-30-2023)
    6.464 Billion USD
    World Rank (Dec-25-2022)
    2,676
    Market Cap (Dec-25-2022)
    5.106 Billion USD
    World Rank (Jan-07-2022)
    2,857
    Market Cap (Jan-07-2022)
    5.93 Billion USD
    Annual Revenue in USD
    2,320 Million USD
    Annual Operating Income in USD
    872 Million USD
    Annual Net Income in USD
    783 Million USD
    Annual Results for Period Ending
    For year ending January-2026
    Headquarters Country
    Company Profile

    Exelixis is a Commercially successful and Oncology Focused Biotechnology company. The company established a broad drug discovery and development platform that has served as the foundation for continued efforts to bring new cancer therapies to patients in need. Headquarters is in USA.

  3. Sino Biopharmaceutical

    World Rank (Aug-2026)
    1,827
    Market Cap (Aug-2026)
    12.683 Billion USD
    World Rank (Jan-05-2024)
    2,021
    Market Cap (Jan-05-2024)
    7.944 Billion USD
    World Rank (Jul-30-2023)
    1,899
    Market Cap (Jul-30-2023)
    8.629 Billion USD
    World Rank (Dec-25-2022)
    1,459
    Market Cap (Dec-25-2022)
    10.655 Billion USD
    World Rank (Jan-07-2022)
    1,423
    Market Cap (Jan-07-2022)
    14.15 Billion USD
    Annual Revenue in USD
    4,026 Million USD
    Annual Operating Income in USD
    844 Million USD
    Annual Net Income in USD
    356 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile
    SINO BIOPHARMACEUTICAL is BioPharmaceutical company with headquarters is in Hong Kong. The products include a variety of biological drugs and chemical drugs, and are in an advantageous position in many potential therapeutic fields such as liver disease, tumor, cardiovascular and cerebrovascular disease, orthopedics, digestive system, anti-infection and respiratory diseases.
  4. ICON Public Company

    World Rank (Aug-2026)
    1,852
    Market Cap (Aug-2026)
    12.492 Billion USD
    World Rank (Jan-05-2024)
    828
    Market Cap (Jan-05-2024)
    22.125 Billion USD
    World Rank (Jul-30-2023)
    897
    Market Cap (Jul-30-2023)
    20.657 Billion USD
    World Rank (Dec-25-2022)
    1,046
    Market Cap (Dec-25-2022)
    15.909 Billion USD
    World Rank (Jan-07-2022)
    935
    Market Cap (Jan-07-2022)
    22.37 Billion USD
    Annual Revenue in USD
    7,733 Million USD
    Annual Operating Income in USD
    877 Million USD
    Annual Net Income in USD
    506 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile

    ICON is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. They have 13,680 employees in 37 countries across 37 countries

  5. Corcept Therapeutics

    World Rank (Aug-2026)
    1,862
    Market Cap (Aug-2026)
    12.374 Billion USD
    World Rank (Jan-05-2024)
    4,813
    Market Cap (Jan-05-2024)
    2.619 Billion USD
    World Rank (Jul-30-2023)
    4,835
    Market Cap (Jul-30-2023)
    2.575 Billion USD
    World Rank (Dec-25-2022)
    5,084
    Market Cap (Dec-25-2022)
    2.223 Billion USD
    World Rank (Jan-07-2022)
    5,900
    Market Cap (Jan-07-2022)
    2.20 Billion USD
    Annual Revenue in USD
    761 Million USD
    Annual Operating Income in USD
    45 Million USD
    Annual Net Income in USD
    100 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    Company Profile
    Corcept Therapeutics is a Pharmaceutical company. It plays an important role in a variety of endocrine, metabolic, oncologic, psychiatric and ophthalmologic diseases. The headquarters is in USA.
  6. Arrowhead Pharmaceuticals

    World Rank (Aug-2026)
    1,882
    Market Cap (Aug-2026)
    12.238 Billion USD
    World Rank (Jan-05-2024)
    3,718
    Market Cap (Jan-05-2024)
    3.710 Billion USD
    World Rank (Jul-30-2023)
    3,705
    Market Cap (Jul-30-2023)
    3.755 Billion USD
    World Rank (Dec-25-2022)
    3,059
    Market Cap (Dec-25-2022)
    4.359 Billion USD
    World Rank (Jan-07-2022)
    2,778
    Market Cap (Jan-07-2022)
    6.16 Billion USD
    Annual Revenue in USD
    829 Million USD
    Annual Operating Income in USD
    98 Million USD
    Annual Net Income in USD
    -2 Million USD
    Annual Results for Period Ending
    For year ending September-2025
    Headquarters Country
    Company Profile

    Bio-pharmaceutical company with headquarters is in California, USA.

  7. Madrigal Pharmaceuticals

    World Rank (Aug-2026)
    1,943
    Market Cap (Aug-2026)
    11.727 Billion USD
    World Rank (Jan-05-2024)
    3,310
    Market Cap (Jan-05-2024)
    4.308 Billion USD
    World Rank (Jul-30-2023)
    3,701
    Market Cap (Jul-30-2023)
    3.759 Billion USD
    World Rank (Dec-25-2022)
    2,892
    Market Cap (Dec-25-2022)
    4.679 Billion USD
    World Rank (Jan-07-2022)
    8,034
    Market Cap (Jan-07-2022)
    1.32 Billion USD
    Annual Revenue in USD
    958 Million USD
    Annual Operating Income in USD
    -300 Million USD
    Annual Net Income in USD
    -288 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    Company Profile

    Madrigal Pharmaceuticals is a Clinical Stage Biopharmaceutical company. It is pursuing novel therapeutics that target a specific thyroid hormone receptor pathway in the liver which is a key regulatory mechanism common to a spectrum of cardio metabolic and fatty liver diseases with high unmet medical need. The headquarters is in USA.

  8. Bio-Techne Corporation

    World Rank (Aug-2026)
    1,999
    Market Cap (Aug-2026)
    11.336 Billion USD
    World Rank (Jan-05-2024)
    1,474
    Market Cap (Jan-05-2024)
    11.453 Billion USD
    World Rank (Jul-30-2023)
    1,331
    Market Cap (Jul-30-2023)
    13.192 Billion USD
    World Rank (Dec-25-2022)
    1,229
    Market Cap (Dec-25-2022)
    12.986 Billion USD
    World Rank (Jan-07-2022)
    1,244
    Market Cap (Jan-07-2022)
    16.32 Billion USD
    Annual Revenue in USD
    1,215 Million USD
    Annual Operating Income in USD
    252 Million USD
    Annual Net Income in USD
    182 Million USD
    Annual Results for Period Ending
    For year ending June-2026
    Headquarters Country
    Stock Category
    Company Profile

    BIO-TECHNE CORPORATION is Biotechnology company with headquarters is in Minnesota, USA. It develops, manufactures and sells instruments, for and services research, diagnostics.

    BIO-TECHNE CORPORATION total number of employees in 2022 was 3,000, a 15.38% increase from 2021.

    BIO-TECHNE CORPORATION annual revenue generated for period ending Jun-2022 was 1,105 Billion USD.

    BIO-TECHNE CORPORATION annual net income generated for period ending Jun-2022 was 271 Billion USD.

  9. Halozyme Therapeutics

    World Rank (Aug-2026)
    2,015
    Market Cap (Aug-2026)
    11.198 Billion USD
    World Rank (Jan-05-2024)
    3,006
    Market Cap (Jan-05-2024)
    4.828 Billion USD
    World Rank (Jul-30-2023)
    2,631
    Market Cap (Jul-30-2023)
    5.749 Billion USD
    World Rank (Dec-25-2022)
    1,883
    Market Cap (Dec-25-2022)
    7.773 Billion USD
    World Rank (Jan-07-2022)
    3,159
    Market Cap (Jan-07-2022)
    5.25 Billion USD
    Annual Revenue in USD
    1,397 Million USD
    Annual Operating Income in USD
    469 Million USD
    Annual Net Income in USD
    317 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    Company Profile

    Halozyme Therapeutics is a Biotechnology Company focused on novel biological and drug delivery approaches. It is having approximately 130 employees. The headquarters is in USA.

  10. Axsome Therapeutics

    World Rank (Aug-2026)
    2,018
    Market Cap (Aug-2026)
    11.192 Billion USD
    World Rank (Jan-05-2024)
    3,584
    Market Cap (Jan-05-2024)
    3.880 Billion USD
    World Rank (Jul-30-2023)
    3,778
    Market Cap (Jul-30-2023)
    3.664 Billion USD
    World Rank (Dec-25-2022)
    3,898
    Market Cap (Dec-25-2022)
    3.204 Billion USD
    World Rank (Jan-07-2022)
    8,340
    Market Cap (Jan-07-2022)
    1.24 Billion USD
    Annual Revenue in USD
    638 Million USD
    Annual Operating Income in USD
    -167 Million USD
    Annual Net Income in USD
    -183 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    Company Profile

    Axsome Therapeutics is a biopharmaceutical company. The headquarters is in USA.

Share

Ads